Medtronic Rebrands Diabetes Business as “MiniMed” Ahead of Spin-Off

What You Should Know: 

– Medtronic announced that its planned New Diabetes Company will be named MiniMed. The name honors the company’s roots, reflecting its original name prior to its acquisition by Medtronic in 2001 and its deep, 40-year history of transforming diabetes care worldwide.

The announcement marks a significant step in the intended separation of Medtronic’s Diabetes business into a new, independent entity.

Simplify Life with Diabetes

The new MiniMed’s mission is to make diabetes more predictable so that everyone can embrace life to the fullest. The company aims to address the constant mental and physical demands required to keep glucose levels in a healthy range, developing technology that helps push the daily burden of diabetes management into the background.

Based in Northridge, California, the Diabetes business consists of a passionate team of more than 8,000 employees. Medtronic is targeting the completion of the planned separation within 18 months of its initial announcement, subject to customary conditions and legal requirements.

“Our journey began in 1983, when visionary entrepreneur Alfred E. Mann founded MiniMed and revolutionized diabetes care with many first-of-its-kind innovations,” said Que Dallara, current EVP and President of Medtronic Diabetes and Chief Executive Officer designate of MiniMed. “We’re thrilled to honor this rich 40-year legacy with a name that carries deep meaning and trust. As we step forward into this new and exciting chapter, we’ll focus relentlessly on fulfilling our Mission.”